Julie Schwartzman, Yusuf Yazici. Show Affiliations »
Abstract
Entities: Chemical Species
Mesh: See more » Antibodies, Monoclonal/adverse effectsAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedBone Density/drug effectsBone Density Conservation Agents/adverse effectsBone Density Conservation Agents/therapeutic useConfounding Factors, EpidemiologicData Interpretation, StatisticalDenosumabFemaleHumansNeoplasms/chemically inducedOsteoporosis, Postmenopausal/drug therapyRANK Ligand
Substances: See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedBone Density Conservation AgentsRANK LigandDenosumab
Year: 2006 PMID: 16738280 DOI: 10.1056/NEJMc060819
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245